Feed DMPHF
DM

Dermapharm Holding SE

DMPHF · OTC

$47.69 +0.00% (+$0.00)
Market Cap 2.11B €
P/E Ratio 14.37x
Div. Yield 2.10%
ROE 22.38%

Bulios Fair Price

$24.68

48.2% downside

Current Price

$47.69

Undervalued Fair Value Overvalued

According to Bulios Fair Price, DMPHF is currently overvalued relative to its market price. How does it work?

Unlock fair price

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Analysis

An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.

Piotroski F-Score Moderate
5/9
Valuation
86 /100
Cheap
P/E 14.37x
EV/EBITDA 8.52x
PEG 0.98x
Growth
30 /100
Declining
EPS growth 0.40%
Rev. growth 4.35%
Book val. growth 9.30%
Profitability
83 /100
Strong
Gross margin 34.74%
Net margin 12.41%
FCF margin 16.21%
Quality
68 /100
Excellent
ROIC 10.18%
ROE 22.38%
Asset turnover 0.53x
Debt
45 /100
Moderate
Debt/Equity 2.18x
Current ratio 1.71x
Net debt/EBITDA 2.69x
Stability
75 /100
Stable
Beta 0.85x
Rev. volatility 7.03%
Profitable years 6

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about DMPHF
Online

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Hans-Georg Feldmeier

Employees

3,500

Headquarters

Grünwald

Upcoming events

12 NOV

Earnings

Upcoming earnings report

31d

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.